FDA PROPOSES BANNING HIGH-RISK CATTLE MATERIAL FROM MEDICAL PRODUCTS

The FDA wants to prohibit companies from using certain cattle material to make drugs, biologics and medical devices to lower the risk of bovine spongiform encephalopathy (BSE or mad cow disease).

Companies would have to keep records proving that any cattle material used in their medical products meets the FDA's requirements, the agency said last week in a new proposed rule.

Under the rule, the banned products could not be used as ingredients in medical products or as a part of their manufacturing processes, the FDA said.